City View Green Holdings Inc. is a Canada-based consumer packaged goods company focused on the development of cannabis-infused edibles. The Company formulates, produces and sells cannabis edibles and related products.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	3.09M 2.18M 1.91M 1.76M 1.64M 206M 3.16M 21.18M 8.18M 102M 8.18M 8M 353M	P/E 2024	-9.02x	P/E 2025	-2.81x
Enterprise Value	3.27M 2.3M 2.01M 1.86M 1.74M 217M 3.34M 22.37M 8.64M 107M 8.64M 8.45M 372M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	84.66%	Yield 2024 *	-	Yield 2025	-

06-01	City View Green Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-28	City View Green Holdings Inc. announced that it has received CAD 0.725 million in funding	CI
04-30	City View Green Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-29	City View Green Holdings Inc. Auditor Raises 'Going Concern' Doubt	CI
04-23	City View Green Holdings Inc. announced that it expects to receive CAD 0.5 million in funding	CI
12-01	City View Green Holdings Inc. announced that it has received CAD 0.325 million in funding	CI
12-01	City View Green Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-24	City View Green Holdings Inc. announced that it expects to receive CAD 0.325 million in funding	CI
25-10-15	ArkenYield Ltd. Enters into Strategic Partnership with Unique Digital Assets Ltd	CI
25-08-29	City View Green Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-07-14	City View Green Holdings Inc. signed a binding letter of intent to acquire 20% stake in Arkenyield for CAD 0.57 million.	CI
25-05-30	City View Green Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-30	City View Green Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

05-29	City View Green : Announces Final Tranche Closing of Private Placement Raising $725,000	PU
05-29	City View Green Holdings Inc. Announces Final Tranche Closing of Private Placement Raising $725,000	NE
05-15	City View Green Holdings Inc. Announces 1st Tranche Closing, the Increase of its Non-Brokered Private Placement and a Shares for Debt Settlement	NE
05-01	City View Green Holdings Inc. Completes Debt Settlements	NE
04-23	City View Green Holdings Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlements	NE

20-10-08	City View Green Holdings Inc. reicht Nachweispaket bei der kanadischen Gesundheitsbehörde ein
20-10-08	City View Green : reicht Nachweispaket bei der kanadischen Gesundheitsbehörde ein

Manager	Title	Age	Since
Roberto Fia CEO	Chief Executive Officer	55	-
Sung Min Myung DFI	Director of Finance/CFO	40	2019-10-03

Icon Exploration Inc Stock Other OTC

Stocks

CA45112R1001

Pharmaceuticals

Valuation: Icon Exploration Inc

Latest news : Icon Exploration Inc

Press Releases: Icon Exploration Inc

News in other languages: Icon Exploration Inc

Quotes and Performance

Managers and Directors: Icon Exploration Inc

Alternative Medicine

Financials

Company Profile

Director	Title	Age	Since
Andrew Peterson CHM	Chairman	78	-
Roberto Fia BRD	Director/Board Member	55	2014-11-09
Steve Naraine BRD	Director/Board Member	-	2023-11-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ICON EXPLORATION INC	-16.24%	-.--%	-	-	2.18M
YUNNAN BAIYAO GROUP CO.,LTD	+3.26%	+0.21%	-13.15%	-6.35%	12.33B
BEIJING TONGRENTANG CO., LTD	+5.18%	+0.21%	-35.64%	-57.79%	4.51B
DONG-E-E-JIAO CO., LTD.	+5.34%	+0.26%	-12.86%	-6.22%	4.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+6.00%	+3.46%	+10.84%	-38.89%	3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.96%	+0.34%	+13.92%	-15.00%	3.58B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+3.90%	+1.85%	-8.91%	-7.63%	3.44B
TASLY PHARMACEUTICAL GROUP CO., LTD	+3.32%	-2.91%	-12.76%	-2.91%	2.91B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+5.85%	-0.46%	-5.88%	-24.18%	2.23B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+2.79%	-1.04%	-12.25%	+25.46%	1.6B
Average	+2.64%	+0.07%	-8.52%	-14.83%	4.26B
Weighted average by Cap.	+4.50%	+0.13%	-10.12%	-15.82%

	2024	2025
Net sales	-	-
Net income	-388K -273K -239K -221K -206K -25.83M -397K -2.66M -1.03M -12.74M -1.03M -1M -44.24M	-1.06M -749K -656K -606K -565K -70.83M -1.09M -7.29M -2.81M -34.94M -2.81M -2.75M -121M
Net Debt	68.01K 47.87K 41.91K 38.69K 36.13K 4.53M 69.56K 466K 180K 2.23M 180K 176K 7.75M	174K 122K 107K 98.95K 92.4K 11.57M 178K 1.19M 460K 5.71M 460K 450K 19.82M